We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

124 hedge funds and large institutions have $519M invested in Amedisys in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $5.5M | Put options by funds: $1.75M

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

17% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 41

15% more capital invested

Capital invested by funds: $452M → $519M (+$67.7M)

3% more funds holding

Funds holding: 120124 (+4)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
124
Holders Change
+4
Holders Change %
+3.33%
% of All Funds
3.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
15
Increased
48
Reduced
41
Closed
11
Calls
$5.5M
Puts
$1.75M
Net Calls
+$3.75M
Net Calls Change
+$5.62M
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
26
Invesco
Georgia
$2.91M -$362K -25,552 -13%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$2.9M -$15K -1,056 -0.6%
BIP
28
Brandes Investment Partners
California
$2.77M +$2.34K +165 +0.1%
Wells Fargo
29
Wells Fargo
California
$2.66M -$11.7M -826,594 -84%
Ameriprise
30
Ameriprise
Minnesota
$2.62M +$105K +7,386 +5%
CCMH
31
Cornerstone Capital Management Holdings
New York
$2.29M +$542K +38,250 +39%
SFM
32
Systematic Financial Management
New Jersey
$2.21M +$215K +15,170 +13%
CS
33
Credit Suisse
Switzerland
$2.04M +$1.44M +101,606 +507%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$2.02M -$1.07M -75,630 -39%
Two Sigma Investments
35
Two Sigma Investments
New York
$1.96M +$1.48M +104,536 +828%
BIM
36
BlackRock Investment Management
Delaware
$1.82M -$228K -16,114 -13%
Arrowstreet Capital
37
Arrowstreet Capital
Massachusetts
$1.42M +$342K +24,159 +40%
DM
38
Deerfield Management
New York
$1.36M -$5.07M -357,601 -81%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$1.33M +$49.6K +3,500 +5%
IIM
40
Ironwood Investment Management
Massachusetts
$1.3M -$143K -10,105 -11%
Prudential Financial
41
Prudential Financial
New Jersey
$1.23M +$19K +1,342 +2%
Public Sector Pension Investment Board (PSP Investments)
42
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.19M +$81.4K +5,742 +9%
New York State Teachers Retirement System (NYSTRS)
43
New York State Teachers Retirement System (NYSTRS)
New York
$1.18M +$7.08K +500 +0.7%
BC
44
Burney Company
Virginia
$1.08M +$39.3K +2,776 +5%
GCP
45
GSA Capital Partners
United Kingdom
$1.04M +$254K +17,914 +40%
TA
46
Teachers Advisors
New York
$1.02M +$14.1K +996 +2%
SO
47
STRS Ohio
Ohio
$891K +$21.3K +1,500 +3%
U
48
UBS
Switzerland
$887K +$95.4K +6,733 +15%
GH
49
GAM Holding
Switzerland
$837K
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$835K -$101K -7,100 -12%

AMED Hedge Fund Activity: Q2 2014 in Review

124 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2014, worth a combined $519M — up 15% from $452M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AMED positions and 11 closed out — a net gain of 4 holders — while 48 added to existing stakes and 41 trimmed.

The largest buyer was North Tide Capital, adding an estimated $11.3M. The largest seller was Wells Fargo, cutting an estimated $11.7M.

  • 124 institutional investors held Amedisys (AMED) as of Q2 2014, up from 120 in Q1 2014.
  • Funds reported $519M of Amedisys stock for Q2 2014, up 15% quarter-over-quarter.
  • 15 funds opened new Amedisys positions in Q2 2014 and 11 closed out, a net change of +4 holders.
  • The largest Amedisys buyer in Q2 2014 was North Tide Capital, an estimated $11.3M added.
  • The largest Amedisys seller in Q2 2014 was Wells Fargo, an estimated $11.7M sold.

Based on aggregated 13F filings for Q2 2014.